Search Results - "HO, D. H"

Refine Results
  1. 1

    Epigenetics and transgenerational transfer: a physiological perspective by Ho, D H, Burggren, W W

    Published in Journal of experimental biology (01-01-2010)
    “…Epigenetics, the transgenerational transfer of phenotypic characters without modification of gene sequence, is a burgeoning area of study in many disciplines…”
    Get full text
    Journal Article
  2. 2

    Perceptions of oral health by those living with mental illnesses in the Victorian Community ‐ The consumer's perspective by Ho, HD, Satur, J, Meldrum, R

    Published in International journal of dental hygiene (01-05-2018)
    “…Objective To understand the way people living with mental illness in an Australian community experience and define oral health. Study population People living…”
    Get full text
    Journal Article
  3. 3

    Mesenchymal tumor cells drive adaptive resistance of Trp53−/− breast tumor cells to inactivated mutant Kras by Weele, Linda J., Djomehri, Sabra I., Cai, Shang, Antony, Jane, Sikandar, Shaheen S., Qian, Dalong, Ho, William H. D., West, Robert B., Scheeren, Ferenc A., Clarke, Michael F.

    Published in Molecular oncology (01-09-2022)
    “…As precision medicine increases the response rate of treatment, tumors frequently bypass inhibition, and reoccur. In order for treatment to be effective long…”
    Get full text
    Journal Article
  4. 4

    Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil by HO, D. H, PAZDUR, R, COVINGTON, W, BROWN, N, YUANG YI HUO, LASSERE, Y, KURITANI, J

    Published in Clinical cancer research (01-09-1998)
    “…Plasma 5-fluorouracil (5-FU) levels were compared in the same patients after approximately equimolar doses (1.9 mmol/ m2/day) of 5-day continuous i.v. infusion…”
    Get full text
    Journal Article
  5. 5

    A mechanistic look at the effects of adversity early in life on cardiovascular disease risk during adulthood by Loria, A. S., Ho, D. H., Pollock, J. S.

    Published in Acta Physiologica (01-02-2014)
    “…Early origins of adult disease may be defined as adversity or challenges during early life that alter physiological responses and prime the organism to chronic…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Expression of ataxin-2 in brains from normal individuals and patients with Alzheimer's disease and spinocerebellar ataxia 2 by Huynh, Duong P., Del Bigio, Marc R., Ho, Diane H., Pulst, Stefan-M.

    Published in Annals of neurology (01-02-1999)
    “…Spinocerebellar ataxia type 2 (SCA2) is caused by expansion of a CAG trinucleotide repeat located in the coding region of the human SCA2 gene. The SCA2 gene…”
    Get full text
    Journal Article
  8. 8

    A Binding Site for Heparin in the Apple 3 Domain of Factor XI by Ho, D H, Badellino, K, Baglia, F A, Walsh, P N

    Published in The Journal of biological chemistry (26-06-1998)
    “…Since heparin potentiates activated factor XI (FXIa) inhibition by protease nexin-2 by providing a template to which both proteins bind (Zhang, Y., Scandura,…”
    Get full text
    Journal Article
  9. 9

    Phenotypic and population differences in the association between CILP and lumbar disc disease by Virtanen, I M, Song, Y Q, Cheung, K M C, Ala-Kokko, L, Karppinen, J, Ho, D W H, Luk, K D K, Yip, S P, Leong, J C Y, Cheah, K S E, Sham, P, Chan, D

    Published in Journal of medical genetics (01-04-2007)
    “…Background: Lumbar disc disease (LDD) is one of the leading causes of disability in the working-age population. A functional single-nucleotide polymorphism…”
    Get full text
    Journal Article
  10. 10
  11. 11

    The Role of High Molecular Weight Kininogen and Prothrombin as Cofactors in the Binding of Factor XI A3 Domain to the Platelet Surface by Ho, David H., Badellino, Karen, Baglia, Frank A., Sun, Mao-Fu, Zhao, Ming-Ming, Gailani, David, Walsh, Peter N.

    Published in The Journal of biological chemistry (18-08-2000)
    “…We have reported that prothrombin (1 μm) is able to replace high molecular weight kininogen (45 nm) as a cofactor for the specific binding of factor XI to the…”
    Get full text
    Journal Article
  12. 12

    Neuronal Expression and Intracellular Localization of Presenilins in Normal and Alzheimer Disease Brains by HUYNH, DUONG P, VINTERS, HARRY V, HO, DIANE H. D, HO, VINH V, PULST, STEFAN-M

    “…The expression patterns of presenilin 1 (PS1) and presenilin 2 (PS2) in human normal and Alzheimer disease (AD) brains were investigated using antibodies to…”
    Get full text
    Journal Article
  13. 13

    In-vitro activity of ramoplanin (a novel lipoglycopeptide), vancomycin, and teicoplanin against Gram-positive clinical isolates from cancer patients by Rolston, K. V. I., Dholakia, N., Ho, D. H., LeBlanc, B., Dvorak, T., Streeter, H.

    Published in Journal of antimicrobial chemotherapy (01-08-1996)
    “…The in-vitro activities of ramoplanin, vancomycin, and teicoplanin against Gram-positive organisms isolated from cancer patients were determined. Ramoplanin…”
    Get full text
    Journal Article
  14. 14

    Depletion of Trp53 and Cdkn2a Does Not Promote Self-Renewal in the Mammary Gland but Amplifies Proliferation Induced by TNF-α by van Weele, Linda J., Scheeren, Ferenc A., Cai, Shang, Kuo, Angera H., Qian, Dalong, Ho, William H.D., Clarke, Michael F.

    Published in Stem cell reports (09-02-2021)
    “…The mammary epithelium undergoes several rounds of extensive proliferation during the female reproductive cycle. Its expansion is a tightly regulated process,…”
    Get full text
    Journal Article
  15. 15

    An inexpensive food cup for use in a commercially available food monitoring system by Wellman, Paul J., Bellinger, Larry L., Cepeda-Benito, Antonio, Susabda, Agnes, Ho, Dao H., Davis, Kristina W.

    Published in Physiology & behavior (15-12-2004)
    “…The microstructure of feeding in rats can be probed using a variety of protocols that employ videotape-based ratings, pellet feeders, and/or laboratory…”
    Get full text
    Journal Article
  16. 16

    Antifungal susceptibility of 44 clinical isolates of Fusarium species determined by using a broth microdilution method by REUBEN, A, ANAISSIE, E, NELSON, P. E, HASHEM, R, LEGRAND, C, HO, D. H, BODEY, G. P

    Published in Antimicrobial Agents and Chemotherapy (01-09-1989)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  17. 17

    In-vitro activity of trovafloxacin against clinical bacterial isolates from patients with cancer by Rolston, K V, Ho, D H, LeBlanc, B, Streeter, H, Dvorak, T

    Published in Journal of antimicrobial chemotherapy (01-06-1997)
    “…The antibacterial activity of trovafloxacin was compared with that of ciprofloxacin, levofloxacin, ofloxacin, sparfloxacin and norfloxacin against bacterial…”
    Get full text
    Journal Article
  18. 18

    Clinical pharmacology of polyethylene glycol-L-asparaginase by Ho, D H, Brown, N S, Yen, A, Holmes, R, Keating, M, Abuchowski, A, Newman, R A, Krakoff, I H

    Published in Drug metabolism and disposition (01-05-1986)
    “…Polyethylene glycol (PEG)-L-asparaginase, at doses ranging from 500 to 8000 units/m2, was infused iv over 60 min in 31 patients of whom 27 were evaluable…”
    Get more information
    Journal Article
  19. 19

    Clinical pharmacology of combined oral uracil and ftorafur by Ho, D H, Covington, W P, Pazdur, R, Brown, N S, Kuritani, J, Newman, R A, Raber, M N, Krakoff, I H

    Published in Drug metabolism and disposition (01-11-1992)
    “…Phase I clinical trials of the combination of oral uracil with ftorafur (Ft) were conducted in patients with solid tumors over either a 5-day (345 mg/m2/day)…”
    Get more information
    Journal Article
  20. 20

    Phase I trial of uracil-tegafur (UFT) plus oral leucovorin : 28-day schedule by PAZDUR, R, LASSERE, Y, DIAZ-CANTON, R. N. E, HO, D. H

    Published in Cancer investigation (1998)
    “…UFT [Taiho Pharmaceutical Co. Ltd., Tokyo, Japan; (BMS-200604), Bristol-Myers Squibb, Princeton, NJ], a fluorouracil prodrug, is an oral 4:1 molar…”
    Get full text
    Journal Article